Table 4.
Presence of a relative cerebellar and brainstem hypoperfusion in the non-VADa and BAC cohort with UIV patients.
Indicators (n) | Hypoperfusion | No hypoperfusion | P |
---|---|---|---|
Non-VAD cohort (n = 43) | 35 (81.40) | 8 (18.60) | 0.005 |
Normal VA cohort (n = 23) | 11 (47.83) | 12 (52.17) | |
Non-VAD side (n = 43) | 26 (60.47) | 17 (39.53) | 0.000 |
VAD side (n = 43) | 9 (20.93) | 34 (79.07) | |
BACb cohort (n = 39) | 30 (76.92) | 9 (23.08) | 0.034 |
Normal BA cohort (n = 27) | 14 (51.85) | 13 (48.15) | |
Opposite of BACc (n = 36) | 25 (69.44) | 11 (30.56) | 0.000 |
BAC side (n = 36) | 5 (13.89) | 31 (86.11) |
All values given as absolute numbers (%). VAD, vertebral artery dominance; BA, basilar artery; BAC, basilar artery curvature.
Defined by the opposite side to the VAD and VAH, and exclude stenosis or occlusion.
Defined by the BAC cohort, exclude VAS or VAO, BAS.
Defined by the opposite direction side to BAC, and clear “C” or “J” type curvature toward either the left or the right sides. And exclude VAS or VAO, BAS.